Search filters

List of works by Ellen M Basu

A phase I/Ib trial targeting the Pi3k/Akt pathway using perifosine: Long-term progression-free survival of patients with resistant neuroblastoma

scientific article published on 20 September 2016

Adoptive immunotherapy with haploidentical natural killer cells and Anti-GD2 monoclonal antibody m3F8 for resistant neuroblastoma: Results of a phase I study

scientific article published on 10 May 2018

Combination of bevacizumab, irinotecan, and temozolomide for refractory or relapsed neuroblastoma: Results of a phase II study

scientific article

Entrectinib in Two Pediatric Patients With Inflammatory Myofibroblastic Tumors Harboring ROS1 or ALK Gene Fusions

scientific article published on 13 September 2018

Extracellular vesicle and particle biomarkers define multiple human cancers

journal article published in 2020

Feasibility of Administering High-Dose (131) I-MIBG Therapy to Children with High-Risk Neuroblastoma Without Lead-Lined Rooms.

scientific article

Humanized 3F8 Anti-GD2 Monoclonal Antibody Dosing With Granulocyte-Macrophage Colony-Stimulating Factor in Patients With Resistant Neuroblastoma: A Phase 1 Clinical Trial

scientific article published on 01 December 2018

IMMU-05. SAFETY AND EFFICACY OF INTRAVENTRICULAR I-LABELED MONOCLONAL ANTIBODY 8H9 TARGETING THE SURFACE GLYCOPROTEIN B7-H3

Ifosfamide, carboplatin, and etoposide for neuroblastoma: a high-dose salvage regimen and review of the literature

scientific article published on 05 September 2012

Image-defined risk factors for nephrectomy in patients undergoing neuroblastoma resection

scientific article published on 02 March 2016

Is Extended Sedation Necessary for Young Children Receiving High-Dose (131) I-MIBG Therapy?

scientific article published on 16 May 2016

Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-GD2 immunotherapy and isotretinoin

scientific article published on 26 November 2015

Local Anesthesia With General Anesthesia for Pediatric Bone Marrow Procedures

scientific article published on 01 August 2019

MYCN-amplified stage 2/3 neuroblastoma: excellent survival in the era of anti-GD2 immunotherapy.

scientific article published on 24 August 2017

Osteochondroma in long-term survivors of high-risk neuroblastoma

scientific article published on 27 February 2015

PDCT-04. SAFETY AND EFFICACY OF INTRAVENTRICULAR I-LABELED MONOCLONAL ANTIBODY 8H9 TARGETING THE SURFACE GLYCOPROTEIN B7-H3 IN PATIENTS WITH CNS/LM DISEASE

scientific article published on 06 November 2017

Phase I trial of anti-GD2 monoclonal antibody hu3F8 plus GM-CSF: Impact of body weight, immunogenicity and anti-GD2 response on pharmacokinetics and survival.

scientific article published on 31 July 2017

Posterior reversible encephalopathy syndrome in neuroblastoma patients receiving anti‐GD2 3F8 monoclonal antibody ⬇️

scientific article published on April 30, 2013

Reduced-Dose Radiation Therapy to the Primary Site is Effective for High-Risk Neuroblastoma: Results From a Prospective Trial

scientific article published on 11 February 2019

Reduced-dose craniospinal irradiation for central nervous system relapsed neuroblastoma

scientific article published on 01 July 2020

SCDT-38. SAFETY AND EFFICACY OF INTRAVENTRICULAR I-LABELED MONOCLONAL ANTIBODY 8H9 TARGETING THE SURFACE GLYCOPROTEIN B7-H3 IN PATIENTS WITH CNS/LM DISEASE

scientific article published on 06 November 2017

Salvage rates after progression of high-risk neuroblastoma with a soft tissue mass

scientific article published on 5 November 2015

Striking dichotomy in outcome of MYCN-amplified neuroblastoma in the contemporary era.

scientific article

Survival Impact of Anti-GD2 Antibody Response in a Phase II Ganglioside Vaccine Trial Among Patients With High-Risk Neuroblastoma with Prior Disease Progression

scientific article published on 16 December 2020

Treatment and outcome of adult-onset neuroblastoma.

scientific article published on 25 March 2018

Treatment and revaccination of children with paraneoplastic opsoclonus-myoclonus-ataxia syndrome and neuroblastoma: The Memorial Sloan Kettering experience

scientific article published on 15 June 2020

When overall survival fails to confirm event-free survival, should the latter be used to set the standard of care?

scientific article published on 17 November 2014

Paulina is supported by:

About Paulina

Help